Elite Pharmaceuticals Stabilizes Stock with New Product Launch Amid Financial Challenges
Elite Pharmaceuticals Inc. is a publicly traded healthcare company that specializes in researching, developing, and manufacturing generic oral controlled-release pharmaceutical products, with a current market capitalization of $454 million USD.
2 minutes to read